Growing Cell Culture Protein Surface Coatings Market in North America to Boost Global Growth

A new market research report has been recently published by Transparency Market Research, titled “Cell Culture Protein Surface Coatings Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020”. The report presents a market overview, product segmentation, market drivers and restraints, geographical segmentation, and the competitive landscape of the global cell culture protein surface coatings market.

According to the research report, in 2013, the global market for cell culture protein surface coatings was worth US$256.2 mn and is estimated to reach a value of US$623.4 mn by the end of 2020. This market is projected to exhibit a progressive 13.60% CAGR between 2014 and 2020.

Increasing investments by major players and governments in the research and development of stem cell is the key factor boosting the demand for cell culture protein surface coatings in the global market. In addition, the commercial manufacture of biologics such as antibodies, proteins, and vaccines and drugs, with the help of cell cultures has helped extensively in inflating the scope of the cell culture technique globally. It has also offered vast business opportunities for the manufacturing companies in the global cell culture protein surface coatings market. Diversity in the applications of stem cells, such as the development of artificial tissue and bone grafts, is further estimated to propel the global market for cell culture protein surface coatings through the forecast period. Moreover, the increasing applications of cell culture in cell-based assays and toxicology studies are further fueling the growth of the market.

Brochure Download: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2993

On the basis of protein source, the global market for cell culture protein surface coatings has been classified into animals, plants, synthetic proteins, and human proteins. The synthetic protein source segment is estimated to exhibit a progressive 13% CAGR between 2014 and 2020. The high growth rate of this segment can be attributed to the growing demand for animal-free surface coatings in several countries in Europe and North America. On the basis of the type of coating, the global market for cell culture protein surface coatings has been divided into pre-coating and self-coating. The pre-coating segment is further sub-categorized into cover slips, flasks, micro-well/multi-well plates, slides, and petri dishes. Among the two major types, in 2013, the self-coating segment held a dominant share in the global market and is expected to remain in that position in the forecast period.

On the basis of geography, the global market for cell culture protein surface coatings has been segmented into Europe, North America, Asia Pacific, and Rest of the World. In 2013, the North America regional market held a 40.90% share in the overall cell culture protein surface coatings market. The rapid development of biotechnology and healthcare infrastructure and increased activities for drug discovery have fueled the Asia Pacific market for cell culture protein surface coatings. This region is projected to exhibit a significant 15.40% CAGR between 2014 and 2020.

Furthermore, the research report covers the competitive landscape of the global market for cell culture protein surface coatings and details the company profile, contact information, business strategies, mergers and acquisitions, financial overview, and recent development of key players. Some of the prominent players operating in the global market for cell culture protein surface coatings are Merck Millipore, Greiner Bio-One International AG, Corning Incorporated, Thermo Fisher Scientific, Inc., Sartorius Stedim Biotech SA, Viogene BioTek Corporation, and Sigma-Aldrich Corporation.

Circulating Tumor Cells (CTCs) Prognostic Technologies Market - Emerging Technologies for Detection, Diagnosis and Treatment

Transparency Market Research has recently announced the publication of a new market research report. The research report, titled “Circulating Tumor Cells (CTCs) Prognostic Technologies Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020,” provides a comprehensive analysis of the global market for circulating tumor cells (CTCs) prognostic technologies. A market overview, product segmentation, market drivers, restraints, market trends, and competitive landscape of the overall market have been analyzed in this research report. According to the research report, the global CTCs prognostic technologies market is estimated to reach US$2.16 bn, exhibiting 26.30% CAGR between 2014 and 2020.

As per the research report, rising prevalence of cancer globally, along with substantial developments in therapeutic monitoring, is expected to propel the global CTCs prognostic technologies market. On the flip side, the high cost associated with CTCs diagnostics, lack of awareness about CTCs prognostic technologies and reluctance for the adoption of these technologies are some of the factors that are expected to hamper the growth of this market in the forecast period.

By technology, the two major segments of the global market for CTCs prognostic technologies include tumor cell detection and tumor cell enrichment. The tumor cell detection segment is further sub-segmented into optical methods and molecular methods. Among these segments, the optical methods segment is projected to exhibit 27.30% CAGR from 2014 to 2020. On the other hand, the tumor cell enrichment segment is divided into immunological and immunomagnetic methods, filtration, and centrifugation. In these sub-segments, immunomagnetic methods accounted for the largest share in the overall tumor cell enrichment segment.

Brochure Download: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2497

By application, the global market for CTCs prognostic technologies has been classified into colorectal cancer, breast cancer, prostate cancer, and others (such as ovarian cancer, lung cancer, and pancreatic cancer). Among these, the prostate cancer segment is estimated to exhibit 25.20% CAGR; whereas, the breast cancer segment is expected to register 27.10% CAGR between 2014 and 2020.

Geographically, the global market for CTCs prognostic technologies has been segmented into Europe, North America, Asia Pacific, and Rest of the World. Among all these regions, North America dominated the overall CTCs prognostic technologies market. The high growth of this region can be attributed to the rising prevalence rate of cancer and increasing adoption of advanced prognostic technologies. On the other hand, Asia Pacific is also expected to register steady growth in the forecast period owing to the estimated rise in different types of cancers along with several research and development initiatives taken by the governments and major players.

Furthermore, the research report evaluates the competitive landscape of the global CTCs prognostic technologies market on the basis of several parameters such as company profile, inception details, financial overview, business strategies, SWOT analysis, mergers and acquisitions, and recent developments. Some of the prominent players operating in the market are Advanced Cell Diagnostics, AdnaGen, Rarecells USA, AVIVA Biosciences Corp., Celula, Veridex, Vitatex, Fluxion Biosciences, Silicon Biosystems, and Epic Sciences.

Steady Growth for Remote Patient Monitoring Market predicted through 2020

Transparency Market Research, a global market intelligence firm, has recently announced the publication of a new research report to their collection. The research report, titled “Remote Patient Monitoring Devices Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020,” provides a detailed study on the global remote patient monitoring devices market.

According to the report, in 2013, the global market for remote patient monitoring devices was worth US$0.38 bn and is anticipated to reach US$0.98 bn by the end of 2020. The market is expected to register a progressive 14.20% CAGR between 2014 and 2020. The rising economic burden on medical clinics and hospitals for patient admission is the major factor propelling the global remote patient monitoring devices market in the forecast period. However, the inadequacy in maintaining the security and privacy of the data is the key factor hampering the growth of this market.

On the basis of type, the global market for remote patient monitoring devices has been divided into breath monitors, physical activity monitors, heart monitors, hematological monitors, and multi-sign monitors. The growing prevalence of various chronic diseases that need constant monitoring, such as blood pressure, diabetes, and cardiovascular disorders, is driving the global market for monitoring medical devices. In 2013, the heart rate monitors segment led the overall market due to the rising prevalence of cardiac diseases across the globe.

Brochure Download: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=401

On the basis of end-use, the global market for remote patient monitoring devices is classified into ambulatory care centers and home healthcare. In 2013, the ambulatory care center segment held the biggest share in the global remote patient monitoring devices market. The dominance of this segment is due to the growing geriatric population, as aging people are at a greater risk of developing various infections and diseases. Nevertheless, the home healthcare segment is also expected to grow at a fast pace in the forecast period.

On the basis of major geographies, the global market for remote patient monitoring devices has been segmented into Europe, Asia Pacific, North America, and Rest of the World. In terms of revenue generation, the North America region dominates the global remote patient monitoring devices market and is also anticipated to remain in that position throughout the forecast period. The dominance of this region is due to the growing geriatric population and increasing healthcare cost in the U.S., making the remote healthcare monitoring treatment option attractive.

In addition, the rising incidence of diabetes in this region is another factor that is anticipated to boost the demand for hematology monitoring devices in the global remote patient monitoring devices market. On the other hand, the Asia Pacific remote patient monitoring devices market is projected to witness rapid growth due to several factors including the increasing costs of healthcare services and the booming medical tourism industry in countries such as Thailand and India.

Furthermore, the research report analyzes the competitive landscape of the global remote patient monitoring devices market based on key criteria such as company profile, financial overview, business strategies, and recent developments. Some of the key players mentioned in the research report are Honeywell HomMed LLC, F. Hoffmann-La Roche Ltd., AMD Global Telemedicine, Covidien plc, Omron Healthcare, Aerotel Medical Systems, Smiths Medical, and Abbott Laboratories.

Medical Devices Outsourcing Aiding Innovation-driven Manufacturing

The global medical devices outsourcing market is a unique and fast-paced one in the currently vast field of outsourcing. Driven primarily by reduced time-to-market strategies, the global medical devices outsourcing market is one of the booming fields in the healthcare industry.

The global medical devices outsourcing market is exhibiting a CAGR of 11.6% from 2012 to 2018. This market was valued at US$21.1 bn in 2012 and is expected to reach US$40.8 before the end of 2018. Multiple parameters can be used to gauge this rate of progress, the most essential one being the competitive landscape. This is governed by the key players of the global medical devices outsourcing market: Avail Medical Products, Micro Systems Engineering GMBH, MDMI Technologies Inc., Active Implants Corporation, Accellent Inc., and CIRTEC Medical Systems LLC. With developing economies reaping the benefits that come with outsourcing, developed economies can consequently provide better services and products, and this applies especially to the healthcare industry.

Developed Nations’ Healthcare Sectors Profit from Growth of Outsourcing

On paper, the process of outsourcing is simple; a company lets another company do a part of the work in order to reduce operational burden for a fraction of the cost. Companies can do without in-house teams with the backing of a strong outsourcing firm, thus creating massive savings in space, time, and costs. This two-way street adds value to both sides of the coin; it provides a much-needed rate of employment to the developing nations and a steady rate of work at a lower price for developed nations. As for the case of the global medical devices outsourcing market, there is a growing trend of the biggest international companies in the medical device manufacturing industry implementing outsourcing measures to ensure constancy in output.

Major Factors that Promote the Growth of Medical Devices Outsourcing

The global medical devices outsourcing market is also driven by a string of pressures on the healthcare industry. These include the shortening lifespans of products, the increasingly smaller range of opportunities left for players to grab, the accelerated rate of improvements in technology that players have to keep up with, and the rising prevalence of diseases. The increasing number of patients suffering from neurological and cardiac diseases makes it extremely important for medical device makers to push themselves to keep up with the increasing population of the afflicted.

Request a Sample of this Report:http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=361

Organized Layouts and Watchful Eyes Aid the Medical Device Outsourcing Market

The universal rule of medical device manufacturing, as with other major aspects of the healthcare industry, is that quality and safety are paramount. Second position in the healthcare industry could change the life and death scenarios for the worse, and therefore, players are constantly focusing on implementing the best practices available.

As for safety of medical devices, various measures are being taken to assure clients that the products are made in order to ensure the highest level of safety. For instance, the medical devices market of India has faced several problems, such as babies being injured or dying inside incubators, and prosthetics causing blood poisoning. To combat this, the health ministry of India had recently formed a materio vigilance program which can ensure the safety of materials being used in medical devices.

The Global Digital Radiology Market Is Expected To Reach a Volume of 158.2 Thousand Units by 2018

Transparency Market Research has published a new report on the global digital radiology market. As per the report, the global digital radiology market is expected to expand at a 5.40% CAGR during the period from 2012 to 2018. The report, titled ‘Digital Radiology Market - Global Industry Size, Market Share, Trends, Analysis, And Forecasts 2012 - 2018’, states that the global digital radiology market is expected to progress from US$9.7 bn in 2012 to US$13.3 bn by 2018.

As the global economy grows, the effects can be clearly seen on the healthcare industry as medical equipment and devices across the globe are being updated with advanced features for efficient results. With this, the medical equipment market is expected to develop faster in the years to come. Major mergers and acquisitions and investments in the global medical device market are boosting the revenue. Irrespective of the recent economic meltdown, the global medical device market continues to develop faster. Modernization of medical equipment, technological advancements, and enhanced healthcare facilities are some of the factors responsible for the growth and development of the global medical device market. Digital radiology, an important segment of the healthcare and medical devices market, is predicted to expand substantially in the years to come.

Some of the factors responsible for the increased adoption of digital radiology are its image capturing superiority, increased patient throughput, increased spending on healthcare infrastructure, and increased application areas. However, exposure to radiation, the growing need of using safer medical devices, high initial capital investment, and high dependability on digital radiographic programs are some of the factors expected to hamper the growth of the global digital radiology market in the years to come. Further, the high noise of digital equipment due to high pixels and requirement of suitable hard-wires could potentially challenge the global digital radiology market in the coming few years.

Request a Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=521

The global digital radiology market is segmented on the basis of geography and device. Based on geography, the global digital radiology market is divided into the Middle East and Africa, Latin America, Western Europe, East Europe, North America, and Asia Pacific. Currently, North America holds close to 41.9% of the global digital radiology market. However, going forward, Western Europe, East Europe, and Asia Pacific are expected to contribute considerably towards the growth of the global digital radiology market. In terms of volume, the global digital radiology market is expected to touch 158.2 thousand units by 2018.

GE Healthcare, Konica Minolta, Inc., Siemens Healthcare, Canon Medical, Fujifilm Holdings Corporation, and Philips Healthcare are some of the leading companies in the global digital radiology market. By device, the global digital radiology market is classified into portable radiography systems, digital detectors, and mobile c-arms. The global digital radiology market is expected to observe a shift from the film-based radiology technique to digital radiology in the next few years owing to benefits such as convenience, speedier and secure data transmission, and better collection and organization of patient information. Innovations in compact and powerful digital medical devices are predicted to propel the global digital radiology market in the near future.

Endocrine Testing Market – Top Reasons Influencing Growth in 2016

According to a new market report published by Transparency Market Research “Endocrine Testing Market - Global Industry Analysis, Size, Share, Growth Trends and Forecast 2015 - 2023” the global endocrine testing market was valued at US$6.1 bn in 2014 and is estimated to reach US$12.8 bn by 2023 at a CAGR of 8.5% from 2015 to 2023.

Browse the full Endocrine Testing Market - Global Industry Analysis, Size, Share, Growth Trends and Forecast 2015 - 2023 report at http://www.transparencymarketresearch.com/endocrine-testing-market.html

Endocrine system is made of endocrine glands that secrete hormones directly into the blood stream. Tests are performed to monitor levels of endocrine hormones (such as Follicle stimulating hormone (FSH), Luteinizing Hormone (LH), estradiol, insulin and others) from biological samples These tests aid in detection of deviation in the hormone production i.e. either hypersecretion (excess secretion) or hyposecretion (less secretion) that results in certain endocrine disorders such as infertility, menopause, thyroid dysfunction and others. The global endocrine testing market is surging due to the rise in geriatric population that is highly susceptible to endocrine system disorders followed by continuous technological advances along with increasing healthcare awareness.

The endocrine testing market has been categorized on the basis of test, diagnostic technology and end-user. Tests type includes major hormone tests, namely, estradiol (E2), Follicle Stimulating Hormone (FSH), Human Chorionic Gonadotropin (hCG), Luteinizing hormone (LH), Dehydroepiandrosterone sulfate (DHEAS), progesterone, testosterone, Thyroid Stimulating Hormone (TSH), prolactin, cortisol and insulin tests. The market accounts for a wide range of conventional as well as rapid diagnostic kits used for detecting either deficiency or excess secretions of these hormones. The thyroid stimulating hormone (TSH) held the major share in the global endocrine testing market, while insulin testing segment is anticipated to be the fastest growing segment during the forecast period.

Request a Sample of This Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1645

The diagnostic technologies segment further describes the technological platforms used in the analysis of the specimen test samples (blood, urine, etc.) and is further categorized into five major technologies as, tandem mass spectrometry, immunoassay, monoclonal and polyclonal antibody, sensor, and clinical chemistry technologies and others. The others segment consists of the technologies such as liquid chromatography, LC-MS/MS technology, and HPLC. The immunoassay technologies dominated the global endocrine testing market by diagnostic technology in 2014, while tandem mass spectrometry is expected to be the fastest growing segment during the forecast period from 2015 to 2023. This was attributed to rigorous use of immunoassays specially Radioimmunoassays (RIA), and Enzyme Linked Assays (EIA) for determination of the levels of the hormone from the biological samples.

The end user segmentation elucidates the endocrine testing market by various end users that include hospitals, commercial laboratories, ambulatory health care centers, home based tests and physician’s offices. Commercial laboratories accounted for the largest market of the global endocrine testing market owing to the usage of specialized diagnostics instruments, presence of dedicated and skilled laboratory personnel, and swift diagnostics services resulting in the growth of the commercial laboratories segment. Advent of telehealth services is expected to further propel the commercial laboratories segment in the near future. However, home based tests is expected to record highest growth in terms of CAGR due to instant result and easy operation of the test kits during the forecast period of 2015 to 2023.

The global endocrine testing market is segmented as given below:

Global Endocrine Testing Market, by Test, 2013-2023 (USD Million)

• Estradiol (E2) Test
• Follicle Stimulating Hormone (FSH) Test
• Human Chorionic Gonadotropin (hCG) Test
• Luteinizing Hormone (LH) Test
• Dehydroepiandrosterone sulfate (DHEAS) Test
• Progesterone Test
• Testosterone Test
• Thyroid Stimulating Hormone (TSH) Test
• Prolactin Test
• Cortisol Test
• Insulin Test
• Others (Gastrin, Thymosin, Secretin, etc.)

Global Endocrine Testing Market, by Diagnostic Technology, 2013 – 2023 (USD Million)

• Tandem Mass spectrometry
• Immunoassay (Enzyme immunoassays, Radioimmunoassays (RIA)) Technologies
• Monoclonal and Polyclonal Antibody Technologies
• Sensor (Electrochemical, Biosensors, etc.) Technologies
• Clinical Chemistry Technologies
• Others (Liquid Chromatography + Mass Spectrometry (LC-MS)

Global Endocrine Testing Market, by End User, 2013 – 2023 (USD Million)

• Hospitals
• Commercial Laboratories
• Ambulatory Care Centers
• Home Based Tests
• Physician Offices

Global Endocrine Testing Market, by Geography, 2013 – 2023 (USD Million)

• North America
  • U.S.
  • Canada
• Europe
  • U.K.
  • Germany
  • Rest of Europe
• Asia-Pacific
  • China
  • Japan
  • Rest of Asia Pacific
• Rest of the World (RoW)
  • Russia
  • Middle East and Africa

Contact us:

Mr. Sudip S

Transparency Market Research

90 State Street,

Suite 700,

Albany

NY - 12207

United States

Tel: +1-518-618-1030

USA - Canada Toll Free 866-552-3453

Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com/

Orthopedic Device Market: 2013 World Market Outlook and Forecast up to 2019

Orthopedic devices are used to restore skeletal structure and joint movements in various types of fractures, abnormal growth of bones, soft tissue damage, trauma or other deformities. These devices can be surgically implanted or externally attached through minimally invasive procedures and hence can be classified as joint implants, internal and external fixation devices. Demand for orthopedic procedures is expected to grow in the near future owing to the increase in geriatric population and obesity across the globe.

The major orthopedic device segments such as joint implants, internal and external fixation devices have been further analyzed on the basis of anatomical locations namely, hip, knee, shoulder, elbow, foot and ankle and other extremities. Spinal orthopedic devices have been segmented into joint implants and internal fixation devices, while craniomaxillo facial devices market include estimations only for internal fixation devices. Various emerging technologies such as bio-absorbable implants and minimal invasive procedures currently form major drivers for the growth of this market. The global orthopedic devices market was valued at USD 29.2 billion in 2012 and is expected to grow at a CAGR of 4.9% from 2013 to 2019, to reach an estimated value of USD 41.2 billion in 2019.

Browse Full Report: http://www.transparencymarketresearch.com/orthopedic-devices-market.html

High incidence rates of osteoporosis, osteoarthritis, obesity along with rapidly aging global population also form key drivers for the global orthopedic devices market. Increase in procedure demand and rise in people opting for minimally invasive surgeries coupled with expanded access in emerging markets are some of the other factors propelling the growth of the market. Introduction of biodegradable implants and internal fixation devices will serve as future growth opportunities for orthopedic devices for various anatomical locations. However, product recalls act as a major growth restraint for the market due to incidences such as adverse side effects to the patient. Device related infections, manufacturing errors, implant loosening, wear debris, corrosion, hypersensitivity and toxicity are some of the other causes leading to orthopedic device failure.

Geographically, North America dominated the global orthopedic devices market and is expected to continue to lead in terms of revenue generation throughout the forecast period. The market in North American region was valued at USD 11.8 billion in the year 2012. Asia-Pacific is considered as the most lucrative market for orthopedic devices market owing to the increase in incidences of bone related disorders and obesity through 2019. The leading players in the market for orthopedic devices market are Depuy Synthes, Zimmer, Stryker, Medtronic, Smith & Nephew, Wright MedicaL, NuVasive, and Globus Medical.

Brochure Download: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1781

Reabsorbable Implants to Lead Conventional Orthopedic Devices

Higher life expectancy, increasing geriatric population, and rising number of osteoporotic patients are the primary factors driving the global orthopedic devices market. Other factors such as higher number of patients having fracture risk such as spine and hip are adding to the growth of the market. Increase in demand for minimally invasive procedures, combined with expanded access to such procedures in emerging markets, is also a major factor propelling growth of the market.Reabsorbable implants are novel orthopedic devices, mainly used for treatment of fractures. Such devices are absorbed by the body, hence second surgery is not required to surgically remove the implant. For such reasons, these devices are preferred over conventional orthopedic devices offering opportunities to the growth of the overall market.However, product recall due to loosening of implants and adverse side effects to patients is a major restraint to the growth of the market. High product costs, fabrication errors, corrosion, and wear and tear are likely to affect market revenue considerably.

The global orthopedic devices market is divided into hip, shoulder, foot and ankle, cranio-maxillofacial, knee, elbow, spine, and other extremities. Based on anatomical location of use of the orthopedic devices, the market is segmented into internal fixation devices, joint implants, and external fixation devices. Of all, the hip devices segment of the overall market is poised to grow at a 5.9% CAGR from 2013 to 2019. The growth of the segment is due to increasing number of hip replacement surgeries and increasing incidence of hip fractures, mainly in the elderly population.

Infusion Pumps Market - Emerging Market Trends and Growth Drivers

Infusion is a technique through which fluids and certain therapeutic drugs can be administered to patients either subcutaneously, arterially, intravenously, or peritoneally. An infusion pump, a specially designed medical device, makes infusions safe and precise. The sheer increase in the number of people suffering from chronic diseases, those undergoing surgeries, or other medical treatments, has pushed up sales of infusion pumps worldwide.

This report studies the state of the global infusion pumps market and tracks present developments to create projections for the growth of the market in the coming years. The forecasting horizon of the report spans from 2013 to 2019. In order to study the global infusion pumps market at multiple levels, the authors of the report have segmented the market into sub-markets on the basis of criteria such as application and geography. A holistic competitive study of the market has also been undertaken to help companies understand their current standing in the global infusion pumps market and compare their strategies against those of others in the market.

Browse Full Report: http://www.transparencymarketresearch.com/infusion-systems-market.html

Revenue is expressed in US$ mn whereas growth has been expressed in CAGR (%). The authors of the report have taken 2011 as a historical year and the base year for the study is 2012.

Overview of the Global Infusion Pumps Market

The global infusion pumps market, which stood at approximately US$5.41 bn in 2012, is projected to exhibit a steady CAGR of 5.3%, and rise in valuation to US$ 7.76 bn by 2019. With an alarming increase in the number of people diagnosed with cancer, diabetes, chronic pain, and other conditions and disease, the need to demand for medical devices that can administer drugs in precise dosages to treat such conditions has seen an uptick. The global infusion pumps market has benefited immensely from this and is expected to do so in the next four years as well.

As the drug delivery process becomes increasingly automated, ‘smart’ infusion pumps are making their presence conspicuously felt on the market. Patients are expected to opt for more smart pumps in the future as they look for less painful, yet more accurate, safe, and convenient drug delivery systems. The trend of home-based healthcare will provide an additional thrust to infusion pump sales. However, the market has suffered a blow in recent years owing to product recalls, which have put several companies’ reputation at stake. Manufacturing defect-free and rigorously tested infusion pumps has thus become central to sustaining a profitable presence in the global infusion pumps market.

Get Sample of Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1601

The demand for large volume infusion pumps has thus far been the highest, and is expected to remain so. Disposable infusion pumps have seen an appreciable share in the global infusion pumps market by product type, but will still continue to trail the large-volume infusion pumps market in terms of sales in the near future. Infusion pumps have been most extensively used for administering clinical nutrition. In the coming years, the demand for infusion pumps during cancer treatments and analgesia will rise.

While North America constitutes the largest infusion pumps market globally, the rise of the Asia Pacific region will be worth watching out, especially with massive demand expected to be seen in India and China.

Companies Mentioned in the Global Infusion Pumps Market Report

The report profiles the following companies in the global infusion pumps market: Hospira, Inc., CareFusion Corporation, Baxter International, Inc., B. Braun Melsungen AG, Fresenius Kabi AG, and Terumo Corporation.

The global infusion systems market is segmented into the following categories:

Global Infusion Pumps Market, by Products

• Large Volume Infusion Pumps
• Disposable Infusion Pumps
• Syringe Infusion Pumps
• Ambulatory Infusion Pumps
• Implantable Infusion Pumps

Global Infusion Pumps Market, by Pumping Channel

• Single Channel Infusion Pumps
• Multiple Channel Infusion Pumps

Global Infusion Pumps Market, by Application Areas

• Analgesia
• Chemotherapy
• Diabetes
• Clinical Nutrition
• Others

Major geographies analyzed under this research report are:

• Europe
• North America
• Asia-Pacific
• Rest of the World

This report gives you access to decisive data such as:

• Market growth drivers
• Factors limiting market growth
• Current market trends
• Market structure
• Market projections for the coming years

Contact us:

Mr. Sudip S

Transparency Market Research

90 State Street,

Suite 700,

Albany

NY - 12207

United States

Tel: +1-518-618-1030

USA - Canada Toll Free 866-552-3453

Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com/

Cancer Diagnostics Market - Emerging Technologies in Healthcare

The global cancer diagnostics market has been witnessing a surge in its valuation, thanks to the rising demand for technically advanced cancer detection methods. The increasing prevalence of cancer around the world is driving this demand significantly. Apart from this, the introduction of non-invasive and advanced techniques for cancer detection is also expected to boost the worldwide cancer diagnostics market in the coming years.

The global cancer diagnostics market is broadly analyzed on the basis of the method of diagnosis and its regional distribution. Based on the method of diagnosis, the market is classified into endoscopy, biopsy, imaging, and tumor biomarker tests. Regionally, it is divided into North America, Europe, Asia Pacific, and the Rest of the World.

This market study has been prepared after extensive research of the worldwide cancer diagnostics market by analysts at TMR. It provides a comprehensive overview of this market on the basis of its historical as well as current performance. Prevailing trends, driving forces, challenges, opportunities, and future prospects of the global cancer diagnostics market have also been discussed at length in this report.

Read Full Report: http://www.transparencymarketresearch.com/cancer-diagnostics-market.html

Overview of the Global Cancer Diagnostics Market

In 2013, the global cancer diagnostics market stood at US$101 bn. Expanding at an estimated CAGR of 7.60% between 2014 and 2020, the market is anticipated to reach a value of US$168.6 bn by the end of the forecast period.

The demand for the imaging technique for cancer detection has been constantly rising, enabling it to maintain its leadership among market segments based on detection method. MRI, mammography, CT, PET, and ultrasound are the prime imaging techniques used for the detection of cancer. Among these, the markets for ultrasound imaging and CT scan hold the leading positions at present.

North America leads the global cancer diagnostics market at present. In 2013, it held a share of 40.7% in the overall market. Europe is the second-largest regional market for cancer diagnostics, which accounted for a share of 29.1% in the global market in 2013.

Analysts expect Asia Pacific to report the fastest CAGR of 8.20% during forecast period. On the other hand, North America is likely to register a CAGR of 7.0% between 2014 and 2020. The increasing incidence of breast cancer in Asia Pacific is the key factor driving the growth of the cancer diagnostics market in this region.

The market for cancer diagnostics in the Rest of World is also expected to post healthy growth in the forthcoming years on account of the increasing prevalence of lung cancer.

On the whole, the global cancer diagnostics market looks will expand impressively over the forecast period. However, the lack of appropriate reimbursement policies is projected to restrict the growth of this market significantly in the near future.

Brochure Download: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=3637

Companies mentioned in the research report

The global cancer diagnostics market is moderately fragmented in nature. GE Healthcare, Siemens, and Philips Healthcare are the key manufacturers of imaging equipment for cancer diagnosis. Abbott Diagnostics, F. Hoffmann-La Roche Ltd., Ambry Genetics, Myriad Genetics, AstraZeneca, Pfizer, and Eli Lily Co. are the major suppliers of oncology diagnostics tests related products in the global arena.

Key Segments of Global Cancer Diagnostics Market

By Method

• Biopsy
• Endoscopy
• Tumor Biomarker Tests
• Imaging

Major regions analyzed under this research report are:

• Europe
• North America
• Asia Pacific
• Rest of the World

This report gives you access to decisive data such as:

• Market growth drivers
• Factors limiting market growth
• Current market trends
• Market structure
• Market projections for the coming years

Contact us:

Mr. Sudip S

Transparency Market Research

90 State Street,

Suite 700,

Albany

NY - 12207

United States

Tel: +1-518-618-1030

USA - Canada Toll Free 866-552-3453

Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com/

Global Medical Courier Market Driven by Rising Demand for Medical Samples

A featured report, titled, “Medical Courier Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020”, from Transparency Market Research provides the latest market insights. According to the report, the global medical courier market is projected to witness positive growth during the forecast period from 2014 to 2020.

The global medical courier market is driven primarily due to the presence of several multinational medical couriers worldwide. By service, the global medical courier market is segmented into clinical labs, hospitals, pharmaceutical and biotechnology industries, medical supplies and equipment, blood banks, and others. These companies offer 24/7 services to their consumers. They also provide a wide range of services in order to meet the expectations of their customers. This ultimately boosts the number of users of medical courier services from pharmaceutical and other industries, in turn, driving the global medical courier market.

Read Full Report : http://www.transparencymarketresearch.com/medical-courier-market.html

Another key driver of the global medical courier market is the rising demand for medical samples across the globe. Due to this rising demand, consumers want faster and more effective delivery of these samples. Several medical courier companies offer this type of delivery service exceeding the customer’s expectations. Moreover, companies operating in the global medical courier market also provide services to transport cord tissue and cord blood. For instance, Americord Registry LLC provides quick transportation of cord tissue and cord blood, which eliminates the extra cost of the express couriers. This cost effectiveness feature offered by various medical courier companies will further propel the global medical courier market.

Many key players in the global medical courier market offer customized services to their customers, which are in compliance with various regulatory bodies, further driving the overall medical courier market. These factors help drive the popularity of a company’s services and attract more customers to such medical courier companies.

Request A Sample Of This Repot:
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=3606

Although the global medical courier market will enjoy positive growth in the coming few years driven by the aforesaid factors, it will be suppressed by certain challenges. Transporting materials such as medical and biotech samples and healthcare equipment, which are delicate in nature, will restrain the market. Another key restraint of the global medical courier market is the high control standards that medical couriers are expected to maintain.

Region-wise, the global medical courier market is classified into Asia Pacific, North America, Europe, and Rest of the World (RoW). Currently, North America dominates the global medical courier market due to the rising demand for the supply of healthcare and biotech equipment and samples in this region. The growing use of courier services by medical laboratories and pharmaceutical industries in Asia Pacific is fueling this regional market.

Some of the key players operating in the global medical courier market are CitySprint Healthcare, Affordable Courier Solutions, Americord Registry, Dynamex, and Blaze Express Courier Service.

The global medical courier market can be segmented as:
By Services:
Hospitals
Clinical labs
Pharmaceutical and biotechnology industries
Blood banks
Medical supplies and equipment
Others
By Regions:
North America
Asia Pacific
Europe
Rest of the World

About Us:
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. 

Emerging Trends in Intraocular Lens (IOL) Market

A research study from Transparency Market Research (TMR) on the global intraocular lens (IOL) market provides the latest insights. This research report is titled, “Intraocular Lens (IOL) Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019”. A detailed segmentation of the global intraocular lens (IOL) market is presented in the study. Broadly, the global intraocular lens (IOL) market is segmented on the basis of material, product type, and region.

Material-wise, the global intraocular lens (IOL) market is divided into collamer, hydrophilic acrylate, silicone, hydrophobic acrylate, and polymethyl methacrylate (PMMA). By product type, the global intraocular lens (IOL) market is classified into phakic, pseudophakic, and aphakic.

Read Full Report : http://www.transparencymarketresearch.com/intraocular-lenses-market.html

The global intraocular lens (IOL) market is driven by the rising geriatric population susceptible to myopia and cataract. The global intraocular lens market will be augmented by the technological advancements in intraocular lenses. Furthermore, the growing adoption of premium intraocular lenses such as toric IOLs, multifocal IOLs, and accommodating IOLs will further have a positive impact on the growth of the global intraocular lens market. Nevertheless, the global intraocular lens market will be suppressed by the high cost associated with the surgical procedures involving the placement of an intraocular lens inside the eye. Another major challenge for the global intraocular lens (IOL) market is the post-operative refractive error.

On the basis of region, the global intraocular lens (IOL) market is segmented into Europe, Asia Pacific, North America, and Rest of the World (RoW). Currently, North America leads the global intraocular lens (IOL) market due to a large number of cataract surgeries that are performed every year in this region. According to the Society of Cataract and Refractive Surgery (ASCRS), around 3 mn cataract surgeries are performed in the United States every year. Moreover, this regional market also benefits from the supportive government initiatives and favorable reimbursement policies. The North America intraocular lens (IOL) market is also driven by the technological innovation in IOLs.

Request A Sample Of This Report :
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2170

The European intraocular lens (IOL) market benefits from the presence of a large geriatric population in this region. Moreover, the initiatives undertaken by the governments in Europe for the benefit of people to perform cataract surgeries will also shape this regional market. On the other hand, the Asia Pacific IOL market and the Rest of the World IOL market are restrained by the lack of proper healthcare facilities in remote places of Asia and Africa.

Some of the key players operating in the global intraocular lens (IOL) market are Abbott Medical Optics, Novartis AG, Carl Zeiss, Eyekon Medical, PowerVision, Physio SA, and Ophtec USA.
The global market for intraocular lens can be segmented as follows:
By materials
Poly(methyl methacrylate) (PMMA)
Silicone
Hydrophobic acrylate
Hydrophilic acrylate
Collamer
By product types
Aphakic
Pseudophakic
Phakic
By geography
North America
Asia Pacific
Europe
Rest of the World

Contact:
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

Cell Surface Markers Market Segment Forecast up to 2018

Cell surface markers are unique to cell types and have vital functional role in immunology. These are generally antigens or molecules present within the plasma membrane of the cell. Such markers serve as the prime component in identification and categorization of cells such as lymphocytes, macrophages, monocytes, tumor cells and other cells majorly related to immunology. Cell surface marker analysis is performed through the use of technologies namely, flow cytometry and hematology analyzers and can be carried out on various samples such as lymph nodes, blood, bone marrow and other tissues. Such analysis may allow simplification of disease diagnosis and identification, sample preparation and drug discovery. Identification of specific types of molecules through cell surface marker analysis helps in efficient disease diagnosis and thereby assists in determination of disease treatment and drugs.

Read Full Report: http://www.transparencymarketresearch.com/cell-surface-markers-market.html

Cell surface markers analysis enables the quantification of the scope of new drugs reaching the intended target and are also responsible for achieving the clinical outcomes by altering the proposed pathophysiological mechanisms. Disease diagnosis by detection or use of cell surface markers has been beneficial and critical in developing innovative and reliable indicators with high specificity for the diagnosis and prognosis of different types of diseases, majorly cancer.

High-throughput tools and techniques in addition to miniature and robust instruments with manifold applications have been the recent need to meet requirements of both research and clinical sectors. Companies investing heavily in developing automated systems with improved sample processing and analysis may gain greater benefits in the near future. Introduction of new and cost-effective instruments is further facilitating the growth of new market entrants and is also being achieved via showcasing advantages of the software and technical capabilities of their instruments at various conferences, laboratories, trade shows, web casting and electronic newsletters.

Get Sample of Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1516

At present, a broad range of assay technologies and solutions for cell surface marker research are available in the market to enable the analysis of gene expression and regulation, genotyping, signal transduction and epigenetic modifications. Some of the most common solutions available for cell surface marker analysis are PCR array, miRNA, pathway reporter, mutation analysis, DNA methylation and protein expression. Complexity of high-end flow cytometers and expensive reagents, controls and analysis systems results into lowering the adoption of sophisticated cell marker analysis solutions, particularly in economically lagged countries. Thus rising preference for lowering healthcare spending by cost containment in diagnosis procedures coupled with rapid and efficient decision making for therapies of specific diseases will further aid in sustaining the growing acceptance of cell surface marker analysis worldwide.

Geographically, North America dominates the global cell surface markers market. As majority of the prime players in the market are domiciled in North America, many technological advancements first are introduced in this region. Growing acceptance of cell surface markers analysis by major industries and verified efficiency in clinical laboratories drives the market for cell surface markers in North America. In addition, factors such as increased market consolidation, simplification of analysis process, cost containment of instruments and reagents and introduction of cheaper products will result in rapid adoption of research in cell surface markers field in the emerging markets. Furthermore, increase in healthcare awareness, affordability, better patient rehabilitation, growth in medical tourism and less competition levels than developed markets will result in growth in demand for identification of cell surface markers and associated disease diagnosis and treatment in emerging economies.

In Vitro Diagnostics Market Dynamics and Opportunities Report by Transparency Market Research

In vitro diagnostic products are medical devices in the form of a reagent, kit, instrument, equipment, apparatus or system and are used either alone or in combination with other diagnostic tools for gaining critical information for health and drug/therapy monitoring. The market landscape for in vitro diagnostics is changing rapidly due to surging demand for IVDs from regions such as Asia-Pacific and Latin America. In 2011, majority share of the in vitro diagnostics market was held by North America and Europe owing to the high healthcare expenditure and structured network of clinical laboratories. However, this scenario is changing gradually since major market players in the in vitro diagnostics market are focusing on emerging economies to accelerate growth via capitalization of unmet opportunities available in these regions.

Read Full Report: http://www.transparencymarketresearch.com/in-vitro-diagnostic-tests.html

Epigenomics-based Diagnostics to be the Emerging Segment in the Global IVD Market

Increase in the global population accompanied with an increase in the cases of chronic infections and diseases such as sexually transmitted diseases (STDs), diabetes, and cancer have led to the growth of the global IVD market. Rising healthcare expenditure across the globe has further boosted the growth of the global IVD market.

The non-invasive and minimally invasive diagnostic tools offered by the global IVD market are preferred by patients and the doctors alike. This fits with the general trend in the medical industry towards minimally invasive procedures, which are more convenient for both parties. However, reimbursement challenges could restrain the growth of the global IVD market. Also, uncertain and ambiguous environmental regulations will threaten the growth of the global IVD market. Molecular diagnostics have opened new channels for the global IVD market. In the coming years, epigenomics-based diagnostics are forecast to be the emerging segment in the global IVD market. Key players in the in vitro diagnostics market are working on introducing epigenomics-based diagnostic products to stay ahead in the competition.

Get Free Sample: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1395

Clinical chemistry IVDs held majority of the market share in 2011, across the U.S, India and China market. However, the molecular diagnostics segment is expected to have a robust growth during the forecast period owing to their ability to detect the disease at an early stage of development. Moreover, dramatic rise in the number of diabetes patients globally is driving the diabetes testing IVDs such as blood glucose meters and glucose testing strips.

Europe followed North America in terms of market share in 2011. This market is majorly driven by the presence of strong healthcare support from public as well as private healthcare spending. Some of the other major factors which drive the in vitro diagnostics market in Europe are:

Rising number of infectious diseases such as pneumonia, tuberculosis, malaria, and sexually transmitted diseases, etc.

Aging population and the related rise in the chronic diseases such as cardiovascular diseases (CVDs), diabetes mellitus, cancer, etc.

Demand for advanced and automated diagnostics technologies

Increasing demand for the rapid diagnostics and point-of-care testing

Significant differences in the reimbursement coverage throughout the region and the presence of ambiguous regulatory environment restraints the growth of this market. Although the healthcare system in Europe is better than many parts in the world, the increasing budgetary pressure is curbing the healthcare expenditure in this region.

This is resulting into slower growth rate of in vitro diagnostics market in Europe in comparison to that of the Asia-Pacific region.

The emergence of molecular diagnostics and the epigenomics-based diagnostics are expected to drive in vitro diagnostics market in Europe. In addition, a trend of diagnostic companies collaborating with pharmaceutical companies to launch companion diagnostics will open a premium segment of in vitro diagnostics market in the near future.

Skincare Devices Market - Global Industry Analysis, Trends and Forecast, 2012 - 2018

A new market research report has been recently published by Transparency Market Research and is available for sale on the company website. The research report, titled “Skincare Devices Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018,” presents a market overview, product segmentation, market drivers, restraining factors, opportunities, geographical segmentation, and competitive landscape.According to the research report, the global skincare devices market is projected to reach US$10.7 bn by the end of 2018, exhibiting a 10.10% CAGR between 2012 and 2018. The research report has made use of graphical representation such as charts and tables to present historical data and forecast figures of the global skincare devices market.

Browse the full Skincare Devices Market (Lasabrasion, Microdermabrasion, Liposuction, LED Therapy, Dermatoscopes, Skin Rejuvenation, Cellulite Reduction, Skin Tightening & Body Contouring and Hair Removal) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018 report at http://www.transparencymarketresearch.com/skincare-devices-market.html

The growing number of ‘medspas’ and booming medical tourism across the globe are the major factors that are expected to boost the demand for skincare devices through the forecast period. In addition, the introduction of minimally-invasive devices for skincare have helped the market gain more consumers, which will indirectly augment the growth of the global skincare devices market in the coming years. On the other hand, the cutthroat competition in this market has resulted in a multitude of research and development projects being undertaken. The price wars for these devices have given consumers greater bargaining authority, which can act as a major restraining factor for the growth of the global skincare devices market.

The global skincare devices market has broadly been divided based on product type into the treatment devices market (such as LED therapy devices, electrosurgical devices, lasabrasion devices, microdermabrasion devices, cryotherapy devices, and liposuction devices,) and diagnostic devices market (such as dermatoscopes, biopsy devices, and image guidance systems). On the basis of application, the global skincare devices market has been classifies into disease diagnosis and treatment, body contouring, skin tightening, skin rejuvenation (to counter problems such as sun damage, wrinkles, acne), damage repair (such as pigmented lesions, vascular, and tattoo removal), hair removal, and cellulite reduction.

Get Sample of Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1244

The research report further divides the global skincare devices market on the basis of geography into North America, Europe, Asia Pacific, and Rest of the World. Among these regions, North America held the largest share of the global skincare devices market and is also expected to maintain its dominant position throughout the forecast period. Nevertheless, the tremendously rising disposable income of consumers in developing nations of the Latin America and Asia are boosting the demand for skincare devices resulting in the market attaining a significant growth rate.

In the last section, the research report covers the competitive landscape of the global skincare devices market comprising the company overview, product portfolio, business strategies, financial overview, SWOT analysis, and recent developments. Some of the prominent players operating in this market are Syneron Medical Ltd., PhotoMedex, Inc., Cynosure, Inc., Cutera, Inc., Lumenis Ltd., and Solta Medical, Inc. Many key players operating in the global skincare devices market are expanding their marketing budgets to increase the level of awareness among the consumers.

Key segments of the Global Skincare Devices market

Global Skincare Devices Market, by Product Type

• Diagnostic Devices Market
• Biopsy Devices
• Image Guidance Systems
• Dermatoscopes
• Treatment Devices Market
• Lasabrasion (Laser Skin Resurfacing) Devices
• Microdermabrasion Devices
• Electrosurgical Devices
• Liposuction Devices
• Cryotherapy Devices
• LED Therapy Devices

Global Skincare Devices Market, by Application

• Disease Diagnosis And Treatment
• Skin Rejuvenation (Acne, Sun Damage, Wrinkles)
• Hair Removal
• Cellulite (Fat) Reduction
• Skin Tightening and Body Contouring
• Damage Repair (Vascular, Pigmented Lesions and Tattoo Removal)

Global Skincare Devices Market, by Geography

• North America
• Europe
• Asia-Pacific
• Rest Of The World (Row)

Contact us:

Mr. Sudip S

Transparency Market Research

90 State Street,

Suite 700,

Albany

NY - 12207

United States

Tel: +1-518-618-1030

USA - Canada Toll Free 866-552-3453

Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com/